Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Outset Ventures
AucklandPre-Seed–Series B$100K – $10M
4 people
Tin Alley Ventures
MelbourneSeed–Late Stage
13 people
YZR Capital
MunichPre-Seed–Growth
12 people
Infinitas Capital
Pre-Seed–Late Stage
17 people
Easton Capital
New YorkSeed–Series B$10M – $20M
7 people
Solasta Ventures
BostonSeed–Series B
6 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
11 people
Presight Capital
SliemaPre-Seed–Growth$500K – $20M
4 people
Capagro
ParisSeries A–Growth$2.2M – $6.6M
9 people
DC Investment Partners
McLeanSeed–Growth$10M
10 people
3xP Global
LisbonSeries A–Series B$1.1M – $10.8M
5 people
Morgenthaler
Portola ValleyPre-Seed–Series C
8 people
Maxpro Ventures
TaipeiSeed–Late Stage
7 people
Artemis Growth Partners
LondonSeed–Series B
1 person
Happiness Capital
Hong KongSeed–Growth
7 people
Ascenta Capital
WilmingtonSeed–Series B$15M – $30M
8 people
Blindspot Ventures Management Co
BostonPre-Seed–Series B
5 people
Medical Incubator Japan K.K.
TokyoSeries A–Series B
11 people
Germin8 Ventures
ChicagoSeed–Series B
9 people
Logos
San FranciscoSeries A–Series B
15 people
Detong Capital
ShanghaiSeed–Growth$20M
11 people
Corner Ventures
New YorkSeed–Late Stage
15 people
HM Venture Partners
San FranciscoSeed–Growth
7 people
Dementia Discovery
LondonSeed–Series C
15 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.
























































































